[EN] VITAMIN D RECEPTOR MODULATORS<br/>[FR] MODULATEURS DE RECEPTEUR DE VITAMINE D
申请人:LILLY CO ELI
公开号:WO2004048309A1
公开(公告)日:2004-06-10
The present invention relates to novel, non-secosteroidal, diaryl compounds with vitamin D receptor (VDR) modulating activity that are less hypercalcemic than 1a,25 dihydroxy vitamin D3. These compounds are useful for treating bone disease and psoriasis.